LAVA Therapeutics N.V.
NASDAQ:LVTX
1.77 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -41.695 | -31.658 | -51.232 | -20.437 | -10.991 |
| Depreciation & Amortization
| 1.278 | 0.781 | 0.633 | 0.606 | 0.294 |
| Deferred Income Tax
| -0.279 | -0.249 | -0.178 | -0.053 | 0 |
| Stock Based Compensation
| 5.039 | 4.113 | 4.429 | 0.683 | 0.218 |
| Change In Working Capital
| -2.827 | 34.113 | 12.286 | 5.708 | 0.705 |
| Accounts Receivables
| 1.694 | -2.7 | 0.774 | -1.309 | 0.037 |
| Inventory
| 0 | 0 | 0 | -0.52 | 0 |
| Accounts Payables
| 0.334 | 1.413 | 1.834 | 0.347 | -0.216 |
| Other Working Capital
| -3.161 | 32.7 | 10.452 | 7.19 | 0.883 |
| Other Non Cash Items
| -0.488 | -3.057 | 1.143 | 0.691 | -0.192 |
| Operating Cash Flow
| -38.972 | 4.043 | -32.477 | -12.765 | -9.775 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.73 | -0.587 | -0.866 | -0.659 | -0.865 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -90.082 | -70.877 | -51.347 | 0 | -0.034 |
| Sales Maturities Of Investments
| 73.177 | 80.81 | 2.846 | 0 | 0 |
| Other Investing Activites
| -15.313 | 9.276 | -42.613 | 0 | -0.029 |
| Investing Cash Flow
| -17.635 | 9.346 | -49.367 | -0.659 | -0.899 |
| Financing Activities: | |||||
| Debt Repayment
| -1.041 | -0.343 | -0.385 | -0.315 | -0.109 |
| Common Stock Issued
| 0 | 0 | 106.783 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -5.858 | -6.153 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.47 | 0.626 | 70.832 | 30.665 | 1.443 |
| Financing Cash Flow
| -0.571 | 0.283 | 171.372 | 24.197 | 1.334 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 1.076 | -4.208 | -4.441 | -1.214 | -0.491 |
| Net Change In Cash
| -56.102 | 9.464 | 85.086 | 9.559 | -9.83 |
| Cash At End Of Period
| 44.231 | 100.333 | 103.019 | 19.429 | 8.326 |